Intelligent Bio Solutions
INBS
9 hedge funds and large institutions have $697K invested in Intelligent Bio Solutions in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
1,215% more capital invested
Capital invested by funds: $53K → $697K (+$644K)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
29% more funds holding
Funds holding: 7 → 9 (+2)
9.82% more ownership
Funds ownership: 0.6% → 10.41% (+9.8%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$898K |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$262K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$198K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$25.4K |
| 2 |
Citigroup
New York
|
-$724 |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$332 |
| 4 |
SWM
SHP Wealth Management
Plymouth,
Massachusetts
|
-$238 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$86 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $435K | +$898K | +130,000 | New |
|
|
2
Alyeska Investment Group
Chicago,
Illinois
| $127K | +$262K | +37,956 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $95.7K | +$198K | +28,609 | New |
|
|
VCM
4
Vanguard Capital Management
Malvern,
Pennsylvania
| $19.4K | +$40.1K | +5,810 | New |
|
|
VFT
5
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
| $13.2K | +$27.3K | +3,958 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4.18K | -$69 | -10 | -0.8% |
|
|
7
UBS Group
Zurich,
Switzerland
| $1.24K | -$25.4K | -3,682 | -91% |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $670 | +$1.38K | +200 | New |
|
|
CW
9
Curio Wealth
Annapolis,
Maryland
| $669 | – | – | – |
|
|
10
Citigroup
New York
| – | -$724 | -76 | Closed |
|
|
11
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$332 | -35 | Closed |
|
|
SWM
12
SHP Wealth Management
Plymouth,
Massachusetts
| – | -$238 | -25 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$86 | -9 | Closed |
|
INBS Hedge Fund Activity: Q1 2026 in Review
9 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q1 2026, worth a combined $697K — up 1,215% from $53K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new INBS positions and 4 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $898K. The largest seller was UBS Group, cutting an estimated $25.4K.
- 9 institutional investors held Intelligent Bio Solutions (INBS) as of Q1 2026, up from 7 in Q4 2025.
- Funds reported $697K of Intelligent Bio Solutions stock for Q1 2026, up 1,215% quarter-over-quarter.
- 6 funds opened new Intelligent Bio Solutions positions in Q1 2026 and 4 closed out, a net change of +2 holders.
- The largest Intelligent Bio Solutions buyer in Q1 2026 was Armistice Capital, an estimated $898K added.
- The largest Intelligent Bio Solutions seller in Q1 2026 was UBS Group, an estimated $25.4K sold.
Based on aggregated 13F filings for Q1 2026.